It is well known that growth factors and proto-oncogenes play a pivotal role in organogenesis as well as in tumor development. The human placenta is a rapidly growing organ which shares some aspects with malignant tumors. We have studied the expression of epidermal growth factor receptor (EGF-R) and the receptor encoded by the c-erbB-2 protooncogene in fm-and third-trimester human placentas. We compared these expression patterns with that of the proliferation marker Ki-67. By immunohistochemistry, EGF-R was intensively expressed in the villous cytotrophoblast in the f m trimester. The apical plasma membrane of the syncytium was weakly stained. In placental villi from the third trimester the reaction product for EGF-R was most intense in single villous cytotrophoblastic & and dong the apical plasma membrane of the syncytium, whereas the basal plasma membrane was much less stained. C-erbB-2 protein product was expressed in the first and third trimesters along the apical membrane of the syncytiotrophoblast. Concerning the extravillous trophoblast in cell islands and cell columns, EGF-R was expressed in the cells proximal to the villous stroma * Correspondence to: M. Castellucci, whereas the distal ells were c-erbB-2 positive. The Ki-67 antibody revealed the proliferative character of the villous cytotrophoblast and of the EGF-R-positive extravillous trophoblast. In contrast, most of the c-erbB-2-positive cells were Ki-67 negative. By in situ hybridization, c-erbB-2 transcripts were found in all types of villous and extravillous trophoblast, including those that did not express c-erbb-2 protein product. Our data indicate that EGF-R expression is strongly related to the proliferative trophoblast and, with advancing pregnancy, to the diffkrentiated villous trophoblast. In contrast, expression of c-erbB-2 protein product occurs only in more advanced stages of trophoblast Merenuation, although transcripts of c-erbB-2 are found in both prolifimtive and e n t i a t e d trophoblast. In addition, the axxpression of EGF-R and c-erbB-2 protein product in the syncytiotrophoblast suggests their involvement in complex regulation of hormones and growth factors. (/Hisrochem Cyrochem 41A45-173, 1993) KEY WORDS: C-erbB-2 protein product; EGFR Immunohistochemistry; In situ hybridization; Human placenta. Benirschke K, Kaufmann P (1990): Pathology of the human placenta. New York, Springer Bishop JM (1987): The molecular genetics of cancer. Science 235:305 Bulmer JN, Morrison L, Johnson PM (1988): Expression of the proliferation markers Ki67 and transferrin receptor by human trophoblast populations. J Reprod Immunol 14291 Bulmer JN, Thrower S, Wells M (1989): Expression of epidermal growth factor receptor and transferrin receptor by human trophoblast population. Am J Reprod Immunol 21:87 Carson S, Chase R, Ulep E, Scommegna A, Benveniste R (1983): Ontogenesis and characteristics of epidermal growth factor receptors in human placenta. Am J Obstet Gynecol 147932 Castellucci M, Classen-Linke I, Muhlhauser J, Kaufmann P, Zardi L, Chiquet-Ehrismann R (1991): The human placenta: a model for tenascin expression. Histochemistry 95:449 Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC Jr. Li Volsi VA, Greene MI (1989): Expression pattern of the neu (NGL) geneencoded growth factor receptor protein (~185"'") in normal and transformed epithelial tissues of the digestive tract.
Introduction
The placenta is a rich source of hormones, growth factors, receptors, and proto-oncogenes which are involved in the rapid growth and differentiation of this organ (for review see Ohlsson, 1989; Adamson, 1987) . It has been emphasized that its normal development has many similarities to malignant tumors (Ohlsson, 1989; Hoekstra and Herscheid, 1985) , e.g., many aspects of trophoblast invasion of the maternal tissue are similar to events that occur during tumor cell invasion (Librach et al., 1991; Fisher et al., 1989;  ~ ~_ _ _ _ Supported by grants from the Deutsche Forschungsgemeinschaft Ka 360/6-5 (PK) and Ka 36017-1 (PK,MC), from the Broglia-Peliti Foundation HN 32/89 and GF41/90 (MC) and from the Consiglio Nazionale delle Ricerche (C.N.R.) 91.00269.PF41 (DZJM,MC). Ohlsson, 1989) . In this context, the genes for growth factors, their receptors, and proto-oncogenes are highly interesting, since expression of such genes represents different levels of vital growth regulatory controls (Ohlsson, 1989; Bishop, 1987) . However, regulatory factors involved in the process of proliferation and differentiation of placental trophoblast remain to be elucidated.
One of the growth factor receptors found in high amounts in the human placenta is the epidermal growth factor receptor (EGF-R) (Ladines-Llave et al., 1991; Bulmer et al., 1989; Lai and Guyda, 1984; Carson et al., 1983) . Binding of EGF to its receptor was found to stimulate the production of both human chorionic gonadotropin (hCG) and human placental lactogen (hPL) ( . The secretion of both hCG and hPL has been proposed to represent subsequent levels of trophoblastic functional differentiation (Hoshina et al., 1982) . It is supposed that EGF, by binding to its receptor, may play a significant role in the induction and regulation of trophoblastic function. In normal human tissue, EGF recep-165 tors are expressed along the plasma membrane of actively proliferating epithelia (Damjanov et al., 1986) . However, until now little evidence has been available that the proliferative cytotrophoblast expresses EGF receptors that could be involved in trophoblastic proliferation.
In several organs the existence of structural and functional relationships between growth factors or growth factor receptors and oncogene products shed a new light on the important role of the latter during growth and development. Several proto-oncogenes have been suggested to be involved in placental development and function (Ohlsson, 1989; Regenstreif and Rossant, 1989; Adamson, 1987; Maruo and Mochizuki, 1987; Pfeifer-Ohlsson et al., 1984; Muller et al., 1983a,b) . A human oncogene related to a growth factor receptor is c-erbB-2. This proto-oncogene, which is also known as neu or HER-2 or HERZlneu, encodes a glycoprotein of 185 KD (p185) which spans the plasma membrane of various cells (Gullick and Venter, 1989) .
C-erbB-2 protein product (p185) and EGF receptor encoded by c-erbB-1 show both structural relationships, especially at their intracellular domain (Akiyama et al., 1986; Yamamoto et al., 1986; Coussens et al., 1985) , and functional relationships by their tyrosin kinase activity. The human proto-oncogene c-erbB-2 may encode a receptor protein for a yet unknown ligand, although some candidate ligands have recently been identified (Perren, 1991; Lupu et al., 1990; Gullick and Venter, 1989) .
The c-erbB-2 gene seems to play a role in human cancer. For example, it is frequently amplified in several human adenocarcinomas (Slamon et al., 1987 (Slamon et al., ,1989 Barnes et al., 1988; Gusterson et al., 1988; Mori et al., 1987; Yokota et al., 1986; Semba et al., 1985) . Recently, c-erbB-2 gene product was demonstrated on cell membranes of epithelial cells of several human fetal (Press et al., 1990; Cohen et al., 1989; Mori et al., 1989; Quirke et al., 1989) and even adult tissues (Press et al., 1990; Cohen et al., 1989; Gullick et al., 1987; Mori et al., 1987) . The physiological role of p185 is still unclear.
To further elucidate the functional role of c-erbB-2 in normal and malignant tissues, the human placenta may be a particularly useful model since its trophoblast comprises highly differentiated villous and invasive extravillous entities (Pijnenborg et al., 1980; Enders, 1968 ) (for review see Ohlsson, 1989) . In some places, i.e., in the columnar trophoblast, both even develop from the identical stem cells. Using the various trophoblast populations of this unique model, the immunohistochemical expression patterns of c-erbB-2 protein product will be compared with c-erbB-2 transcripts as seen by in situ hybridization. Moreover, a comparison will be drawn with expression patterns of EGF receptor in the light of the abovementioned structural and functional relationships.
Materials and Methods

Materials
Fifteen first-trimester placentas were obtained from legal abortions at 7-12 weeks of pregnancy, Ten full-term placentas were obtained from spontaneous deliveries after uncomplicated pregnancies. One to four specimens were excised from each placenta.
Tissue Preparation
Placental tissue was cut in blocks measuring 0.5 cm3. For immunohistochemistry, most of the tissue blocks were snap-frozen in liquid nitrogen and stored at -20°C. Cryostat sections (5 pm) were mounted on uncoated glass slides and were air-dried at room temperature for a few minutes. Some of the sections were fixed in 100% acetone at 4°C for 10 min and stored at 4°C until use (up to one night from sectioning). Others were stored unfixed at 4'C. Other tissue blocks were fixed either in 4% neutral buffered formalin or in an acid-alcohol fixative solution (Folkvord et al., 1989) . Tissue was fixed for 1-6 hr or overnight at 4°C. rapidly dehydrated, and embedded in paraffin at temperatures not exceeding 56°C. Paraffin sections (6 pm) were cut and stretched at 45'C, allowed to dry, and stored at 4°C until use. For in situ hybridization, samples were fixed in a freshly prepared solution of 4% paraformaldehyde in PBS for 2 hr at 4°C. Tissue blocks were then soaked at 4°C in a solution of 30% RNAse-free sucrose, embedded in Tissue-Tek OCT compound (Miles Scientific; Naperville, IL), frozen in liquid nitrogen, and stored at -60°C until use.
Immunohistochemistry
Frozen sections were processed without pre-treatment. Paraffin sections were deparaffinized and rehydrated in xylene and a graded series of ethyl alcohol before being incubated for 15 min with 1% hydrogen peroxide in methanol to inhibit endogenous peroxidases. Frozen and paraffin sections were incubated for 20 min at room temperature with non-immune porcine serum (or with non-immune rabbit serum in the case of primary monoclonal antibody). Afterwards the sections were incubated with one of the five primary antibodies (see Table 1 ) for 45 min at room temperature or overnight at 4'C. Sections were then washed in PBS before further treatment for avidin-biotin-peroxidase complex.
Avidin-Biotin Complex (ABC) Method. For frozen and paraffin sections two kits were used, the first containing avidin (rabbit anti-mouse ABC kit) (Dakopatts; Glostrup, Denmark), and the other streptavidin (S-ABC goat anti-rabbit streptavidin-biotin system) (Zymed Laboratories; South San Francisco, CA). Both kits used peroxidase enzyme as a label and peroxidase activity was revealed by diaminobenzidine (Sigma; St Louis, MO). Kit instructions were followed with regard to dilutions and incubation times. The sections were then mounted with an aqueous mounting solution.
Controls. For the above immunohistochemical procedures controls were performed replacing the primary antibody by 10% non-immune serum or by PBS. Further controls were performed omitting the secondary antibody. The controls were always negative.
I n Situ Hybridization (ISH)
A detailed protocol for in situ hybridization utilizing anti-sense RNA probes was published previously (Hofler et al., 1986) . After pre-treatment of the tissue sections with proteinase K and acetic anhydride, 10 pI of the hybridization mixture, containing hybridization buffer [SO% formamide, 2 x SSC (1 x SSC = sodium salt citrate, 0.15 M NaCI, 0.015 M trisodium citrate), 10% dextran sulfate, 0.25% bovine serum albumin, 0.25% Ficoll 400, 0.25% polyvinylpyrrolidone (PVP) 360, 0.5% sodium dodecyl sulfate (SDS), 250 pglml denatured salmon sperm DNA (ssDNA)] and the antisense RNA probe (1 x 10' cpm of 3H-labeled anti-sense RNA) were applied to each tissue section. Hybridization was carried out at 50°C (= 25'C below Tin) for 16 hr. Non-hybridized RNA was removed from the tissue sections by RNAse A treatment and this was followed by three washing steps at 37°C in 2 x SSC, 1 x SSC, and finally 0.1 x SSC, 10 min each. For autoradiography, the slides were dipped in NTB-2 (Eastman Kodak;
Rochester, NY), dried, and stored desiccated at 4' C and exposed for 14 days.
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Controls. Nonspecific (pGEM1) vector sequences as well as "sense" RNA probes were employed to determine sensitivity. These experiments resulted in negative hybridizations, both on blots and in situ. Chemography in the ISH assays was excluded by the use of hybridization buffers without probes, followed by autoradiography (data not shown).
Probes. c-RNA probes 0.4 KB long for hybridization studies were generated by transcription of linearized RNA expression vectors (pGEM1) containing sequences encoding parts of the transmembranous and intracellular domain of human c-neu (Bargmann et al., 1986) . The probes were synthesized to a specific activity of 4 x 10' cpm/pg RNA by incorporation of 3H-labeled UTP.
In specimens from the first trimester of gestation, strong immunostaining for EGF-R was found along the entire plasma membrane of the cytotrophoblast, and a weaker reaction product was present along the apical plasma membrane of the syncytiotrophoblast (Figure 1) . No immunoreactivity was observed throughout all stages of pregnancy in the cytoplasm of both syncytiotrophoblast and cytotrophoblast. In full-term placentas there was a slightly different expression pattem of EGF receptor (Figures 2a and 2b) : the apical plasma membrane of the syncytiotrophoblast was strongly labeled, whereas the basal plasma membrane was weakly stained. Only a few cytotrophoblastic cells were immunoreactive for EGF receptor along their plasma membranes. In fmt-and third-trimester placentas, villous stromal cells were negative for EGFR.
The c-erbB-2 (neu) immunoreactivity was remarkably different from that of EGFR. Villous cytotrophoblast was usually not found to express c-erbB-2 protein product. In contrast, immunoreactivity was found along the apical plasma membrane of the syncytiotrophoblast in first-and third-trimester placentas (Figures 3 and 4) . When the polyclonal antibody was used, a few stromal cells, probably fibroblasts, showed weak cytoplasmic staining for c-erbB-2
Results
The immunohistochemical results are summarized in Table 2 . The monoclonal and the polyclonal antibodies to c-erbB-2 protein product gave similar results in the placental tissues used in this study. In addition, various methods of fixation and embedding revealed identical expression patterns. Therefore, no separate description will be provided. which was not evident when the monoclonal antibodies were applied.
cytotrophoblast attached to the tips of some large-caliber villi (Figure 5a) . Immunoreactivity of the EGF receptor along the cytotrophoblastic plasma membranes in such islands showed a peculiar distribution pattern. Juxtastromal cytotrophoblast was prominently labeled. With increasing distance from the stroma of the adherent villus, immunoreactivity was decreasing. Cells in a more peripheral position showed only weak or no immunoreactivity (Figure 5b ).
Cell Islands and Cell Columns
Cell islands are large accumulations of predominantly extravillous The distribution of c-erbB-2 protein was largely inverse to that of EGF-R. Juxtastromal cytotrophoblast of cell islands showed no c-erbB-2 immunoreactivity (Figure 5c ). As revealed in serial sections, these cells were identical to those that were heavily stained for EGFR. With increasing distance from the adjacent villous stroma the intensity of labeling increased, so that cytotrophoblasts in a more peripheral position expressed a higher amount of c-erbB-2 protein (Figure 5c ). Cell columns are structurally comparable to cell islands. They attach large-caliber villi, so-called anchoring villi, to the basal plate. In the cell columns, expression patterns for EGF receptor and c-erbB-2 were the same as described above for the cell islands. EGF-R immunoreactivity decreased from the anchoring villus towards the invasive trophoblast of the basal plate, and immunoreactivity for c-erbB-2 protein increased in the same direction.
Immunostaining with Ki-67 Antibody
To study possible relations between EGF receptor, c-erbB-2 oncoprotein, and trophoblastic proliferation, we used the monoclonal antibody Ki-67, which reacts with a nuclear antigen present only in proliferating cells. From serial sections it became evident that the expression pattern of Ki-67 was most prominent in those trophoblastic cells of all cell islands and cell columns that were positive for EGFR (Figure 5d ). On the other hand, extravillous trophoblast cells that expressed c-erbB-2 protein were largely negative for the anti-Ki-67 antibody, i.e.. the expression of Ki-67 decreased with increasing distance from the villous stroma. Labeling of villous cytotrophoblast in early pregnancy showed a few proliferating cells per villus, whereas in term placentas only occasional cells were stained. Villous syncytiotrophoblast was always negative.
In Situ Hybridization Analyses
After in situ hybridization with a 3H-labeled c-neu cRNA probe, we obtained signals specific for c-neu mRNA transcripts only in trophoblast. The results showed a selective labeling with equal intensity of the cytoplasm of both villous cytotrophoblast and villous syncytiotrophoblast in all stages of pregnancy ( Figures 6, 7a and  7b ). Furthermore, in situ hybridization showed a homogeneous labeling pattern over all cytotrophoblastic cells of the cell islands and columns ( Figure 6) . No difference in the labeling pattern was detectable between the juxtastromal and the peripheral extravillous cytotrophoblast.
Discussion
The placental trophoblast consists of a continuous multinucleated layer of syncytiotrophoblast and of the underlying mononucleate cytotrophoblastic cells. The syncytium increases in mass only by fusion with the cytotrophoblast, which represents the undifferentiated proliferative stem cell. Therefore, the syncytium is a terminally differentiated epithelial structure responsible for most exchange and secretory functions of the placenta (for reviews see Benirschke and Kaufmann, 1990; Fox, 1978) .
Other aspects of trophoblast differentiation are present in the extravillous trophoblast of cell islands and cell columns. Many ultrastructural (Okudaira et al., 1971; Enders, 1968) . immunohistochemical (Autio-Hmainen et al., 1991; Castellucci et al., 1991; Bulmer et al., 1988 Bulmer et al., ,1989 Yeh and Kurman, 1989; Gosseye and Fox, 1984; Kurman et al., 1984) . and in situ hybridization studies (Hunt et al., 1991) suggest that cell columns present a continuous spectrum of differentiation in which the proliferative cells are proximally and the most differentiated cells are distally located from the villous core. Cell islands seem to be largely corresponding structures which are not in contact with the basal plate (Castellucci et al., 1991) .
The balance between proliferation and differentiation ultimately determines the structure and function of the developing placenta and is related to its "pseudomalignant" properties. Because of this, in the present investigation we have studied the expression of EGFR and c-erbB-2 and have compared these results with the immunolocalization ofthe proliferation marker Ki-67. Although EGFR and c-erbB-2 are involved in cell proliferation, differentiation, and tumor malignancy (for the literature see the Introduction, and for reviews see Velu, 1990; Gullick and Venter, 1989) , there have been only a few reports describing comparative immunohistochemical localization of p185 and EGFR (e.g., Tsutsumi et al., 1990) .
By immunohistochemistry, both proteins in the human placenta were expressed along the plasma membranes of placental trophoblast and of cell islands and cell columns, but in a stage-and differentiation-specific pattern. C-erbB-2 protein product was linked to differentiated structures such as the villous syncytiotrophoblast and the distally located extravillous cytotrophoblastic cells (Ki-67 negative) of cell islands and cell columns. It was not expressed in the proliferative villous and extravillous cytotrophoblast. In contrast, EGF-R was most heavily expressed on proliferative ( a -6 7 positive) villous and extravillous cytotrophoblast. In addition, with advancing pregnancy EGF-R showed increasing immunoreactivity along , the highly differentiated syncytiotrophoblast plasma membranes.
One of the most interesting fiidings ofthis study is that c-erbB-2 cRNA was detected throughout both villous trophoblastic layers and in all cytotrophoblastic cells in cell islands and cell columns, whereas the gene product was not expressed in the proliferating trophoblast. It can be stated that although cRNA is present in high amounts in proliferative structures (Ki-67 positive), the translation of c-erbB-2 mRNA occurs when the cell has reached a higher degree of differentiation. Therefore, it is possible that in the human placenta the expression of the c-erbB-2 protein product is involved in functions peculiar to the differentiated tissue and not in proliferation.
This is the first study showing by immunohistochemistry and in situ hybridization the distribution of c-erbB-2 protein product and c-erbB-2 mRNA in a normal tissue allowing suggestions for regulatory functions. Comparable biochemical data were observed by Dati et al. (1990) during mammary gland development. They found that in the developing normal mammary gland c-erbB-2 mRNA and protein are expressed solely when the tissue has reached its functional differentiation, i.e., particularly in the lactating gland. Moreover, they observed that in cancer cell lines, arrest of cell growth induced by a steroid-depleted medium was accompanied by a strong increase of c-erbB-2 mRNA and of c-erbB-2-encoded p185 protein.
On the other hand, we must consider some previous reports suggesting that under certain conditions the c-erbB-2 protein product is capable of conveying mitogenic signals (Lee et al., 1989; Lehvaslaiho et al., 1989) .
The fact that EGFR and c-erbB-2 protein product are coexpressed only in the villous syncytiotrophoblast but not in extravillous cytotrophoblast has interesting implications. Stimulation of the EGF-R tyrosine kinase leads to its autophosphorylation and to phosphorylation of tyrosine residues from various cell substrates (Velu, 1990) . Several proteins have been reported to be tyrosine phosphorylated in vivo by the EGF receptor kinase. One of them is the p185 (King et al., 1988; Kadowaki et al., 19&7) . Although the exact mechanism of interaction between these two proteins is unknown, it is known that phosphorylation of cell substrates and autophosphorylation of the EGFR after addition of ligand are followed by several early and delayed responses. The delayed responses indude induction of specific "As (such as c-fos, c-myc, and c-jun protooncogenes) as well as DNA synthesis. The early events include the stimulation of phosphatidylinositol 4,S-biphosphate (PIP2), the increase in intracellular Ca2+ concentration, and stimulation of different transport systems (Velu, 1990) . It is well known that these early and delayed responses are highly involved in complex regulations of hormone, growth factor, and receptor expression, events that are highly developed in the syncytium, where the c-erbB-2 and EGFR are co-expressed.
On the other hand, the different complementary expression of EGF-R and c-erbB-2 in cell islands and cell columns may be in accordance with their generally reduced endocrine activities (Gosseye and Fox, 1984) (for review see Benirsrhke and Kaufmann, 1990) .
The divergent expression patterns of c-erbB-2 protein product and of EGFR in villous as compared with extravillous trophoblast may suggest different roles of both proteins in these two functionally different sites of trophoblast development.
